摘要
地塞米松是一种长效糖皮质激素。大剂量地塞米松即40mg/d连用4d单独或联合其他药物治疗多发性骨髓瘤、免疫性血小板减少症、霍奇金淋巴瘤、非霍奇金淋巴瘤和急性淋巴细胞白血病的疗效确切,近年来已逐渐被纳入相关治疗指南或专家共识中。
Dexamethasone is a prolonged action glucocorticoid. Because of the exact effects, high-dose dexamethasone with 40 mg/d for 4 consecutive days used alone or combined in treating multiple myeloma, immune thrombocytopenia, Hodgkin＇s lymphoma, non-Hodgkin＇s lymphoma and acute lyrnphoblastic leukemia has been brought into related guidelines and consensus recently.
出处
《上海医药》
CAS
2013年第3期17-21,共5页
Shanghai Medical & Pharmaceutical Journal
